Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ale Algra is active.

Publication


Featured researches published by Ale Algra.


Trials | 2006

Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET). Protocol for a randomised controlled trial of decompressive surgery in space-occupying hemispheric infarction

Jeannette Hofmeijer; G Johan Amelink; Ale Algra; Jan van Gijn; Malcolm R. Macleod; L. Jaap Kappelle; H. Bart van der Worp

BackgroundPatients with a hemispheric infarct and massive space-occupying brain oedema have a poor prognosis. Despite maximal conservative treatment, the case fatality rate may be as high as 80%, and most survivors are left severely disabled. Non-randomised studies suggest that decompressive surgery reduces mortality substantially and improves functional outcome of survivors. This study is designed to compare the efficacy of decompressive surgery to improve functional outcome with that of conservative treatment in patients with space-occupying supratentorial infarctionMethodsThe study design is that of a multi-centre, randomised clinical trial, which will include 112 patients aged between 18 and 60 years with a large hemispheric infarct with space-occupying oedema that leads to a decrease in consciousness. Patients will be randomised to receive either decompressive surgery in combination with medical treatment or best medical treatment alone. Randomisation will be stratified for the intended mode of conservative treatment (intensive care or stroke unit care). The primary outcome measure will be functional outcome, as determined by the score on the modified Rankin Scale, at one year.


European Stroke Journal | 2018

Prediction models for clinical outcome after a carotid revascularisation procedure: A systematic review:

Eline J. Volkers; Ale Algra; L. Jaap Kappelle; Jacoba P. Greving

Introduction Prediction models for clinical outcome after carotid artery stenting or carotid endarterectomy could aid physicians in estimating peri- and postprocedural risks in individual patients. We aimed to identify existing prediction models for short- and long-term outcome after carotid artery stenting or carotid endarterectomy in patients with symptomatic or asymptomatic carotid stenosis, and to summarise their most important predictors and predictive performance. Patients and methods We performed a systematic literature search for studies that developed a prediction model or risk score published until 22 December 2016. Eligible prediction models had to predict the risk of vascular events with at least one patient characteristic. Results We identified 37 studies that developed 46 prediction models. Thirty-four (74%) models were developed in carotid endarterectomy patients; 27 of these (59%) predicted short-term (in-hospital or within 30 days) risk. Most commonly predicted outcome was stroke or death (n = 12; 26%). Age (n = 31; 67%), diabetes mellitus (n = 21; 46%), heart failure (n = 16; 35%), and contralateral carotid stenosis ≥50% or occlusion (n = 16; 35%) were most commonly used as predictors. For 25 models (54%), it was unclear how missing data were handled; a complete case analysis was performed in 15 (33%) of the remaining 21 models. Twenty-eight (61%) models reported the full regression formula or risk score with risk classification. Twenty-one (46%) models were validated internally and 12 (26%) externally. Discriminative performance (c-statistic) ranged from 0.66 to 0.94 for models after carotid artery stenting and from 0.58 to 0.74 for models after carotid endarterectomy. The c-statistic ranged from 0.55 to 0.72 for the external validations. Discussion Age, diabetes mellitus, heart failure, and contralateral carotid stenosis ≥50% or occlusion were most often used as predictors in all models. Discriminative performance (c-statistic) was higher for prediction models after carotid artery stenting than after carotid endarterectomy. Conclusion The clinical usefulness of most prediction models for short- or long-term outcome after carotid artery stenting or carotid endarterectomy remains unclear because of incomplete reporting, methodological limitations, and lack of external validation.


Brain | 2005

Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms

Marieke J.H. Wermer; I. C. van der Schaaf; B.K. Velthuis; Ale Algra; Erik Buskens; Gabriel J.E. Rinkel


The New England Journal of Medicine | 2002

Warfarin or aspirin for recurrent ischemic stroke [1] (multiple letters)

Stephanie Lewis; Peter Sandercock; Ale Algra; David H. Hsi; Darrick J. Alaimo; Gianfranco Butera; Massimo Chessa; Mario Carminati; J. P. Mohr; J. L P Thompson; B. Levin; William J. Powers


Archive | 2012

TreatmentofBrainArteriovenousMalformations A Systematic Review and Meta-analysis

Janneke van Beijnum; H. Bart van der Worp; Dennis R. Buis; Rustam Al-Shahi; L. Jaap Kappelle; Jan Willem; Berkelbach van der; W. Peter Vandertop; Ale Algra; C.J.M. Klijn


Archive | 2013

Subarachnoid Hemorrhage Endovascular Coiling Versus Neurosurgical Clipping for Patients With Aneurysmal

Gabriel J.E. Rinkel; Irene C. van der Schaaf; Ale Algra; Marieke J. Wermer; Andrew J. Molyneux; Mike Clarke


Archive | 2012

Aneurysmal Subarachnoid Hemorrhage Endovascular Coiling Versus Neurosurgical Clipping for Patients With

Jan van Gijn; Gabriel J.E. Rinkel; Irene C. van der Schaaf; Ale Algra; Marieke J. Wermer; Andrew J. Molyneux


/data/revues/14744422/v10i7/S1474442211701090/ | 2011

Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis

Monique H M Vlak; Ale Algra; Raya Brandenburg; Gabriel J.E. Rinkel


Hart Bulletin | 2010

Paracetamol may improve recovery after a stroke: Results of the Paracetamol (Acetaminophen) In Stroke (PAIS) trial

Heleen den Hertog; Bart van der Worp; Maarten van Gemert; Ale Algra; Jaap Kappelle; Jan van Gijn; Peter J. Koudstaal; D.W.J. Dippel


Archive | 2000

Commentary Is clopidogrel superior to aspirin in secondary prevention of vascular disease

Ale Algra; Jan van Gijn

Collaboration


Dive into the Ale Algra's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B.K. Velthuis

University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C.J.M. Klijn

University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge